UBS sets a price target of $21 for NASDAQ:CCOI, indicating a potential upside of 12.99%.Robbins Geller Rudman & Dowd LLP investigates potential violations of U.S. federal securities laws by Cogent Communications.The stock price of CCOI has seen a significant decrease of 29.36%, with current trading around $18.59.Cogent Communications Holdings, Inc. (NASDAQ: CCOI) is a provider of internet services, primarily focusing on offering high-speed internet access and data transport services. The company operates in ...

Core Viewpoint - Wealthfront Corporation is under investigation for potential violations of federal securities laws following a significant decline in its stock price and net deposit outflows after its IPO [1][4]. Group 1: Company Overview - Wealthfront completed its Initial Public Offering (IPO) on December 12, 2025, offering 34,615,384 shares at $14.00 per share [3]. - The company reported its first quarterly results as a publicly traded entity on January 12, 2026, showing net deposit outflows of $208 million, a significant drop from $874 million in inflows during the same period the previous year [4]. Group 2: Financial Performance - Following the earnings call on January 12, 2026, Wealthfront's stock price fell by $2.12, or approximately 16.8%, closing at $10.47 on January 13, 2026 [4]. - Since the IPO, Wealthfront's share price has decreased by $5.20, or about 37.1%, from $14.00 on December 12, 2025, to $8.80 on January 20, 2026 [5]. Group 3: Management Insights - CEO David Fortunato attributed the decline in deposits to falling interest rates and highlighted the strategic importance of the company's new home-lending business [4]. - Fortunato disclosed that he owns a 95.1% stake in Wealthfront's home-lending business and mentioned the possibility of revisiting the ownership structure [4].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential violations of securities laws by Chagee Holdings Limited and its executives regarding misrepresentation or failure to disclose information to investors [1] Group 1: Investigation Details - The investigation focuses on the losses suffered by investors and the possibility of recovering these losses under federal securities laws [1] - Investors who purchased Chagee securities and experienced losses are encouraged to join the investigation [2] Group 2: Whistleblower Information - Individuals with nonpublic information about Chagee are advised to consider assisting the investigation or utilizing the SEC Whistleblower program, which may offer rewards of up to 30% of any successful recovery [3] Group 3: About Johnson Fistel, PLLP - Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with multiple offices across the United States, representing both individual and institutional investors in securities class action lawsuits [4]

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. for violations of the Securities Exchange Act, alleging that the company made false and misleading statements regarding its growth prospects during a specific period [1][2]. Summary by Sections Class Action Details - The class period for the lawsuit is from June 20, 2025, to September 24, 2025, with a deadline for lead plaintiff appointments set for January 2, 2026 [2]. - The complaint claims that CarMax's optimistic growth statements were misleading, as the company's recent growth was influenced by customer speculation about tariffs on vehicle purchases [2]. Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the DJS Law Group for potential participation in the lawsuit, with no obligation or cost to join [3]. Law Group Information - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4].

Core Viewpoint - Molina Healthcare, Inc. is under investigation by Faruqi & Faruqi, LLP for potential claims related to securities law violations [1] Group 1 - Faruqi & Faruqi, LLP is a prominent national securities law firm with a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [1] - The investigation was announced on July 7, 2025, prior to the market opening, indicating a significant development for Molina Healthcare [1]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential securities law violations at WPP plc following a significant drop in its stock price after a disappointing trading update [2][3][4] Company Performance - WPP's stock price fell from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, marking a decline of approximately 18.1% in just one day [2][4] - The company reported a deterioration in performance for Q2 2025, attributing this to macroeconomic uncertainties affecting client spending and weaker-than-expected new business [3][4] Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in WPP to discuss their legal options, indicating potential claims against the company [1][2] - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [2]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential securities law violations at James Hardie Industries following a significant drop in profit and disappointing earnings guidance [2][3]. Financial Performance - On August 19, 2025, James Hardie Industries reported a 29% drop in profit for the first quarter of 2025 and provided lower-than-expected earnings guidance for fiscal 2026, attributing the decline to high borrowing costs [3]. - Following the earnings announcement, James Hardie's American Depositary Receipts (ADRs) fell by $9.79, or 34.4%, closing at $18.64 per ADR on August 20, 2025 [3]. Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in James Hardie to contact them to discuss potential legal options [1][2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [2].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against MediaAlpha, Inc. for possible violations of federal securities laws and unlawful business practices [2][6]. Investigation Details - The investigation follows a report by Wolfpack Research alleging that MediaAlpha engaged in consumer fraud, particularly in its health insurance segment, claiming that up to 78% of its lead-buying partners were involved in fraudulent activities [6]. - MediaAlpha's stock price experienced significant declines following these allegations, dropping 11.84% after the initial report and 27.7% after the FTC's letter regarding misleading claims [6]. Legal Actions - On August 6, 2025, MediaAlpha announced a settlement with the FTC for $45 million, related to claims that it misled consumers and sold their information to telemarketers [6]. - The FTC's complaint indicated that MediaAlpha sold approximately 119 million leads about consumers in 2024 alone [6]. Next Steps - Investors who suffered losses and wish to discuss their legal rights are encouraged to contact Bragar Eagel & Squire, P.C. for further information [4]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various complex litigations across the United States [5].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Encompass Health Corporation due to allegations of violations of federal securities laws and poor performance on safety measures in their hospitals [1][3]. Group 1: Allegations and Investigations - A New York Times article reported that Encompass's for-profit hospitals perform below average on key safety measures, with 34 facilities rated by Medicare as having significantly worse rates of preventable readmissions [3]. - The investigation by Bragar Eagel & Squire focuses on whether Encompass has engaged in unlawful business practices related to these allegations [1][3]. Group 2: Stock Market Impact - Following the publication of the allegations, Encompass's stock price dropped by $12.39, or 10.4%, closing at $107.28 per share on July 15, 2025, resulting in financial harm to investors [4]. Group 3: Legal Support for Investors - Investors who purchased Encompass shares and suffered losses are encouraged to contact Bragar Eagel & Squire for potential legal recourse [5].